Edition:
United States

Reata Pharmaceuticals Inc (RETA.OQ)

RETA.OQ on NASDAQ Stock Exchange Global Market

84.99USD
3:23pm EDT
Change (% chg)

$-5.01 (-5.57%)
Prev Close
$90.00
Open
$90.00
Day's High
$90.48
Day's Low
$83.59
Volume
74,435
Avg. Vol
105,741
52-wk High
$93.93
52-wk Low
$19.32

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Jun '18 7.57 -1.078
Mar '18 32.39 0.153
FY 2017 Dec '17 9.96 -0.638
Sep '17 12.56 -0.495
Jun '17 12.81 -0.518
Mar '17 12.73 -0.318
FY 2016 Dec '16 12.50 -0.185
Sep '16 12.55 -0.040
Jun '16 12.37 -0.050
Mar '16 12.44 -0.013
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Sep-18 6 10.08 12.50 7.55 9.71
Quarter Ending Dec-18 6 9.73 12.50 7.55 9.71
Year Ending Dec-18 6 59.78 65.00 55.06 46.93
Year Ending Dec-19 6 44.06 59.31 28.90 81.32
Earnings (per share)
Quarter Ending Sep-18 7 -0.78 -0.57 -1.12 -0.46
Quarter Ending Dec-18 7 -0.76 -0.33 -1.12 -0.46
Year Ending Dec-18 7 -2.47 -1.91 -3.16 -2.20
Year Ending Dec-19 7 -3.28 -2.48 -3.98 -3.02
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 108.51 32.45
P/E High - Last 5 Yrs. -- 279.56 47.46
P/E Low - Last 5 Yrs. -- 98.19 24.76
Beta -- 0.62 0.87
Price to Sales (TTM) 42.75 109.91 6.31
Price to Book (MRQ) -- 12.50 3.81
Price to Tangible Book (MRQ) -- 18.78 5.83
Price to Cash Flow (TTM) -- 62.06 23.35
% Owned Institutions -- 0.00 0.00

Dividends

  Company industry sector
Dividend Yield -- 0.35 1.73
Dividend Yield - 5 Year Avg -- 0.21 1.45
Dividend 5 Year Growth Rate -- 2.59 -5.47
Payout Ratio(TTM) -- 5.87 46.56

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -40.87 176.70 8.47
Sales (TTM) vs TTM 1 Yr. Ago 23.51 93.28 6.75
Sales - 5 Yr. Growth Rate -- 24.52 7.58
EPS (MRQ) vs Qtr. 1 Yr. Ago -134.12 278.78 25.58
EPS (TTM) vs TTM 1 Yr. Ago -105.14 -- --
EPS - 5 Yr. Growth Rate -- 23.69 7.60
Capital Spending - 5 Yr. Growth Rate -- 38.72 8.44

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.61 2.19
Current Ratio (MRQ) 3.09 5.46 2.96
LT Debt to Equity (MRQ) -- 14.93 11.41
Total Debt to Equity (MRQ) -- 18.35 14.25
Interest Coverage (TTM) -152.00 -202.84 35.04

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 55.99 54.86
Gross Margin - 5 Yr. Avg. -- 52.63 53.37
EBITD Margin (TTM) -80.83 -- --
EBITD - 5 Yr. Avg -- -174.66 15.90
Operating Margin (TTM) -83.14 -602.22 3.68
Operating Margin - 5 Yr. Avg. -- -188.17 10.98
Pre-Tax Margin (TTM) -84.99 -599.02 3.98
Pre-Tax Margin - 5 Yr. Avg. -- -190.53 11.16
Net Profit Margin (TTM) -85.01 -594.39 0.72
Net Profit Margin - 5 Yr. Avg. -- -188.29 7.49
Effective Tax Rate (TTM) -- 11.59 20.36
Effective Tax Rate - 5 Yr. Avg. -- 19.14 24.27

Efficiency

  Company industry sector
Revenue/Employee (TTM) 671,871 5,161,374 703,739,345
Net Income/Employee (TTM) -571,129 -5,875,094 81,128,873
Receivable Turnover (TTM) -- 5.34 5.02
Inventory Turnover (TTM) -- 2.04 3.61
Asset Turnover (TTM) 0.51 0.38 0.81

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -43.18 0.84 9.67
Return on Assets - 5 Yr. Avg. -- 2.59 10.83
Return on Investment (TTM) -76.45 1.61 12.63
Return on Investment - 5 Yr. Avg. -- 2.06 13.94
Return on Equity (TTM) -- 0.35 14.80
Return on Equity - 5 Yr. Avg. -- -2.36 15.32
  1 Year 3 Year 5 Year
Sales % -3.61 -2.56 --
EPS (TTM) % -533.88 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Reata Pharmaceuticals Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 53.79%
# of Holders: 143
Total Shares Held: 12,765,653
3 Mo. Net Change: 897,589
# New Positions: 25
# Closed Positions: 15
# Increased Positions: 88
# Reduced Positions: 42
# Net Buyers: 46
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.